Andy Lane is the Commercial Director at The Native Antigen Company. As the number of cases of COVID-19 began to climb in late 2019, labs began collecting and sequencing patient isolates. Within weeks, the first draft sequence of the SARS-CoV-2 genome was published, opening the gates for a wave of early research (1). At the time, one of the major questions surrounding SARS-CoV-2 was its natural mutation rate. It has long been understood that viral genomes naturally mutate over time.
Andy Lane
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Andy
Contact Andy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack